Menu

克立硼罗全新购买方式一览

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Introduction: Criborole is a topical phosphodiesterase 4 inhibitor (PDE4) drug approved by the FDA for the treatment of mild to moderate atopic dermatitis in adults and pediatric patients 3 months and older. The FDA approved criborole for use in children 2 years and older in December 2016 and in March 2020 for children 3 months and older. Criborole may be used in a continuous treatment regimen or intermittently, depending on the patient's symptoms of atopic dermatitis and the area of ​​skin affected.

List of new ways to purchase Criborole

1. Hospital pharmacies: It has been launched in China and can be purchased in domestic hospital pharmacies. After being diagnosed with atopic dermatitis, the doctor may prescribe Criborole to the patient, and the patient can bring the prescription to the hospital pharmacy to purchase the drug.

2. Clinics or outpatient clinics: In addition to hospital pharmacies, some large clinics or outpatient clinics also provide criborole purchase services. You can inquire at the hospital pharmacy or clinic and submit a prescription to purchase criborole.

3. Online pharmacies: Some online pharmacies can purchase Criborole by uploading a prescription. Before purchasing, you must choose a trustworthy and certified online pharmacy.

4. Specific drug dealers: In addition to the channels provided by medical institutions, some specific drug dealers may also provide sales services for criborole. You can inquire at local pharmacies or drug dealers about whether criborole is sold.

Efficacy of criborole in the treatment of atopic dermatitis

In clinical trials after 28 days of continuous use of criborole, 31.4%-32.8% of patients achieved Investigator's Static Global Assessment (ISGA) 0-1 (clear or almost clear) and had at least grade 2 improvement since the start of the trial, compared with 18%-25.4% of patients using vehicle alone.

The Investigator's Static Global Assessment is a 5-point scale on which the investigator conducts an overall clinical assessment of atopic dermatitis based on signs and symptoms. Research shows that criborole can also reduce symptoms of atopic dermatitis, such as itching, redness, lichen-like thickening, oozing rashes, and sore, scratched lesions, with some patients reporting improvements in these symptoms after about a week of using criborole.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。